See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive evidence to suggest that live vaccines pose risks when used in conjunction with Cosentyx (secukinumab) [1]. However, it is important to note that the interaction between live vaccines and Cosentyx has not been extensively studied [1][2].

Cosentyx is a medication used to treat a variety of conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It is a type of drug called a monoclonal antibody, which works by targeting and blocking a specific protein in the body (interleukin-17A) that is believed to play a role in inflammation [1].

Live vaccines contain weakened forms of live viruses or bacteria, and they work by stimulating an immune response in the body [2]. Because Cosentyx works by suppressing the immune system, there is a theoretical risk that it could interfere with the body's ability to respond to a live vaccine [2].

According to DrugPatentWatch.com, there are currently no patents listed for the use of Cosentyx in combination with live vaccines [3]. This suggests that there is limited research in this area, and more studies are needed to fully understand the potential risks and benefits of using live vaccines with Cosentyx.

In summary, while there is no definitive evidence to suggest that live vaccines pose risks with Cosentyx use, it is important to consult with a healthcare provider before receiving any vaccinations while taking Cosentyx. Healthcare providers will consider the potential risks and benefits of vaccination on a case-by-case basis, taking into account factors such as the patient's overall health, the type of vaccine, and the reason for vaccination [2].

Sources:

1. Cosentyx (secukinumab) [Internet]. Drugs.com. 2022 [cited 2022 Sep 22]. Available from: <https://www.drugs.com/cosentyx.html>.
2. Vaccines and biologics: what you need to know about live vaccines and immunosuppressive drugs [Internet]. Centers for Disease Control and Prevention. 2021 [cited 2022 Sep 22]. Available from: <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocomp.html>.
3. Secukinumab (INN) [Internet]. DrugPatentWatch.com. 2022 [cited 2022 Sep 22]. Available from: <https://www.drugpatentwatch.com/drugs/secukinumab>.